TRPM8 antagonist 3

CAS No. 2102179-29-1

TRPM8 antagonist 3( —— )

Catalog No. M28848 CAS No. 2102179-29-1

TRPM8 antagonist 3 is a blocker of TRPM8 (IC50 = 11 nM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 86 In Stock
5MG 78 In Stock
10MG 122 In Stock
25MG 201 In Stock
50MG 287 In Stock
100MG 405 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    TRPM8 antagonist 3
  • Note
    Research use only, not for human use.
  • Brief Description
    TRPM8 antagonist 3 is a blocker of TRPM8 (IC50 = 11 nM).
  • Description
    TRPM8 antagonist 3 is a blocker of TRPM8 (IC50 = 11 nM).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    TRP/TRPV Channel
  • Recptor
    D3 receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2102179-29-1
  • Formula Weight
    292.315
  • Molecular Formula
    C13H12N2O4S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 25 mg/mL (85.53 mM)
  • SMILES
    O=C(C1=C(O)N=C(C2=CC=CC=C2O)S1)N3OCCC3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Grundt P, et al. Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor. J Med Chem. 2005 Feb 10;48(3):839-48.
molnova catalog
related products
  • ASP7663

    ASP7663 is a?TRPA1 Receptor Agonist?and exhibiting an abdominal analgesic effect in vivo.?

  • RN-1747

    RN-1747 is a selective transient receptor potential cation channel subfamily V member 4 agonists (EC50: hTRPV4 of 0.77 μM, mTRPV4 of 4.0 μM, and rTRPV4 of 4.1 μM). RN-1747 also antagonizes TRPM8 (IC50: 4 μM).

  • Pico145

    Pico145 is a remarkable inhibitor of TRPC1/4/5 channels. Pico145 inhibits (?)-englerin A-activated TRPC4/TRPC5 channels.